Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (1878)	1/24/2002 8:30:03 PM
From: Ward Knutson	Read Replies (1) of 2515

<<Regards the fraud, did you ask BTRN management why they were selling share at open market while proposing secondary (which may be at deep discount). Whose interest they were protecting, and working for? Miljenko>> Careful, because you don't have a clue what you are talking about. The shares registered and sold by "BTRN management" were in reality those being sold by prior management of Eligix. They did so shortly after the closing of the merger with BTRN. Careless use of the word fraud pal, there is nothing improper re: their actions. This is not unlike your prior characterization of the Irofulven Phase III as a "desperate move". Point: you portray yourself as a voice of knowledge - I would assume (on your part) a requisite, basic understanding of the facts to which you are speaking in advance of making such broad-sweeping statements. In neither of the above did you fully comprehend, or even attempt to gain insight to, the true situation(s).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next